Global Gene Therapy Market Estimated to Reach US$ 325 Million by 2015

The gene therapy market is expanding worldwide at an impressive rate, and continuous technological developments will continue to spur the growth, says RNCOS.

NOIDA, India (prHWY.com) April 5, 2012 - Across the globe, the gene therapy market has progressed rapidly in the past few years due to technological advancements and active participation by private and public players. According to a new research report by RNCOS, the global gene therapy industry holds enormous growth potential, despite being at a nascent stage, as some key products are under development that may positively impact the market in the coming years. With the very first launch of Gendicine in China, the global market continued to witness the entry of new players and instances of technical agreements. These developments have made the market lucrative, and it is expected that it will reach the US$ 325 Million-mark by 2015.

Research Analysis & Highlights

The 120-page comprehensive report, "Global Gene Therapy Market Analysis", spread provides an in-depth research and rational analysis of the current status and expected position of the Global Gene Therapy Market. The study presents forecasts for the industry, projecting the potential market to be generated by key gene therapy products to be launched in future. It analyzes the opportunities for companies in the global gene therapy market, in terms of key vectors and leading technologies. The extensive research also includes the analysis of the advanced gene therapy drugs and the recent industry developments to provide a balanced outlook on the market potentials.

Some of the key findings of the report are:

- Allovectin-7 (velimogene aliplasmid) will generate estimated US$ 400 Million sales in the United States.
- Adenovirus Vector leads the gene therapy market usage.
- Oncology is the major therapeutic area for the market participants.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM282.htm

Some of our Related Reports are:

- Cancer Monoclonal Antibodies Market to 2015 (http://rncos.com/Report/IM375.htm)
- Global Biosimilars Market Forecast to 2015 (http://www.rncos.com/Report/IM379.htm)
- US Biotech Market Analysis (http://www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (http://www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (http://www.rncos.com/Report/IM361.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: gene therapy pfizer

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code